Addiction

Breda University develops VR tool to resist alcohol temptation during festive season

BREDA, Netherlands, Dec. 1, 2025 /PRNewswire/ -- With the festive season approaching, traditionally a risky period for people recovering from alcohol…

3 weeks ago

Randi Zuckerberg to Host Catalyst at BHASe Summit 2026 After Standing-Room-Only Debut at eCapWest

LAKEWOOD, N.J., Nov. 25, 2025 /PRNewswire/ -- February 11–13, 2026 — Every once in a while, a moment reminds an…

4 weeks ago

BrainsWay to Host Virtual Analyst & Investor Day to Discuss the Company’s Growth Strategy and Deep TMS™ Treatment December 1, 2025

BURLINGTON, Mass. and JERUSALEM, Nov. 25, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),…

4 weeks ago

Neuphoria Therapeutics Inc. Sends Letter to Stockholders

Files Definitive Proxy Statement for 2025 Annual Meeting of Stockholders Urges Stockholders to Vote “FOR” BOTH Neuphoria Therapeutics Nominees on WHITE Proxy Card…

4 weeks ago

SciSparc: Neurothera Labs Announces Israeli Patent Application in Collaboration with Clearmind Medicine for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression

TEL AVIV, Israel, Nov. 20, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera…

1 month ago

Nexalin’s 15 Milliamp Neurostimulation Device Demonstrates Promising Results in Treating Gambling Disorder with Alcohol Use Comorbidity

Peer-reviewed case report published in The American Journal on Addictions highlights significant clinical improvement and sustained abstinence following Nexalin’s non-invasive…

1 month ago

Clearmind Medicine Announces Positive Top-Line Results from First Cohort of its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder

Vancouver, Canada, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a…

1 month ago

Ensysce Biosciences Reports Third Quarter 2025 Financial Results

~ Third Quarter Highlighted by Initiation of Phase 3 Study of PF614, Underscoring Progress Toward Market Readiness and Commitment to…

1 month ago

Loosid Secures Funding from AWS to Bring AI-Powered Sobriety Support to the Workplace with Launch of SAM™AI for Enterprise

MIAMI, Nov. 13, 2025 /PRNewswire/ -- Loosid, the leading clean and sober lifestyle brand, today announced that it has secured…

1 month ago